Differential Pathogen-Specific Immune Reconstitution in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Children

Abstract Background Susceptibility to coinfections in human immunodeficiency virus (HIV)-infected patients remains increased despite antiretroviral therapy (ART). To elucidate mechanisms involved in immune reconstitution, we studied immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in children before and after ART. Methods We prospectively enrolled 25 HIV-infected children to study HIV-, cytomegalovirus (CMV)-, and tuberculosis (TB)-specific T-cell responses before and 1 year after initiation of ART using intracellular cytokine (interleukin-2, interferon-γ, tumor necrosis factor-α) staining assays after in vitro stimulation. We further measured expression of activation, immune exhaustion, and memory phenotype markers and studied proliferative responses after antigen stimulation. Results We observed differential, pathogen-specific changes after 1 year of ART in cytokine profiles of CD4 T-cell responses that were associated with shifts in memory phenotype and decreased programmed cell death 1 (PD-1) expression. The proliferative capacity of HIV- and PPD-specific responses increased after 1 year of ART. Of note, the recovery of CMV- and TB-specific responses was correlated with a decrease in PD-1 expression (r = 0.83, P = .008 and r = 0.81, P = .0007, respectively). Conclusions Reconstitution of immune responses on ART is associated with alterations in T-cell phenotype, function, and PD-1 expression that are distinct for HIV, TB, and CMV. The PD-1 pathway represents a potential target for immunotherapy in HIV-infected patients on ART with insufficient immune reconstitution.

[1]  R. Wilkinson,et al.  PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis , 2018, Front. Immunol..

[2]  P. Goulder,et al.  Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia , 2018, AIDS.

[3]  Jing Wu,et al.  PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis , 2016, Scientific Reports.

[4]  B. Walker,et al.  Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection , 2016, Science Translational Medicine.

[5]  S. Lewin,et al.  Paediatric HIV infection: the potential for cure , 2016, Nature Reviews Immunology.

[6]  E. Wherry,et al.  HIV Skews the Lineage-Defining Transcriptional Profile of Mycobacterium tuberculosis–Specific CD4+ T Cells , 2016, The Journal of Immunology.

[7]  P. Klenerman,et al.  Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era , 2015, Front. Microbiol..

[8]  N. Garrett,et al.  Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype , 2015, The Journal of Immunology.

[9]  A. Antinori,et al.  Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients. , 2014, The Journal of infection.

[10]  Jeffrey N. Martin,et al.  Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease , 2014, AIDS.

[11]  D. Farber,et al.  Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.

[12]  J. Ananworanich,et al.  Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency , 2013, PloS one.

[13]  D. Mitra,et al.  Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis. , 2013, The Journal of infectious diseases.

[14]  M. Paiardini,et al.  HIV‐associated chronic immune activation , 2013, Immunological reviews.

[15]  D. Heckerman,et al.  A high-dimensional immune monitoring model of HIV-1-specific CD8 T cell responses accurately identifies subjects achieving spontaneous viral control , 2012, Retrovirology.

[16]  A. Marchant,et al.  Functional Exhaustion of CD4+ T Lymphocytes during Primary Cytomegalovirus Infection , 2012, The Journal of Immunology.

[17]  S. Lawn,et al.  Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community , 2012, PloS one.

[18]  A. Sher,et al.  Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. , 2012, Blood.

[19]  G. Kaplan,et al.  Functional Capacity of Mycobacterium tuberculosis-Specific T Cell Responses in Humans Is Associated with Mycobacterial Load , 2011, The Journal of Immunology.

[20]  F. Pereyra,et al.  Responsiveness of HIV-specific CD4 T cells to PD-1 blockade. , 2011, Blood.

[21]  J. Reynes,et al.  Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection. , 2011, Blood.

[22]  R. Haubrich,et al.  Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection. , 2011, Blood.

[23]  R. Heyderman,et al.  Bronchoalveolar CD4+ T cell responses to respiratory antigens are impaired in HIV-infected adults , 2011, Thorax.

[24]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[25]  A. Sher,et al.  CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition , 2011, The Journal of Immunology.

[26]  R. Koup,et al.  Preferential infection and depletion of Mycobacterium tuberculosis–specific CD4 T cells after HIV-1 infection , 2010, The Journal of experimental medicine.

[27]  S. Rowland-Jones,et al.  Polyfunctional CD4+ and CD8+ T Cell Responses to Tuberculosis Antigens in HIV-1–Infected Patients before and after Anti-Retroviral Treatment , 2010, The Journal of Immunology.

[28]  R. Wilkinson,et al.  HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. , 2009, American journal of respiratory and critical care medicine.

[29]  G. Maartens,et al.  Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis. , 2009, American journal of respiratory and critical care medicine.

[30]  G. Kaplan,et al.  HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guérin vaccine. , 2009, Journal of Infectious Diseases.

[31]  R. Shafer,et al.  Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  V. Appay,et al.  Phenotype and function of human T lymphocyte subsets: Consensus and issues , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[33]  D. Lilleri,et al.  Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. , 2008, The Journal of infectious diseases.

[34]  A. d’Arminio Monforte,et al.  Response to combination antiretroviral therapy: variation by age , 2008, AIDS.

[35]  B. Gärtner,et al.  PD‐1 Expression and IL‐2 Loss of Cytomegalovirus‐ Specific T Cells Correlates with Viremia and Reversible Functional Anergy , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  C. Giaquinto,et al.  Immune reconstitution in human immunodeficiency virus type 1‐infected children with different virological responses to anti‐retroviral therapy , 2007, Clinical and experimental immunology.

[37]  E. Rosenberg,et al.  Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction , 2007, Nature Immunology.

[38]  G. Pantaleo,et al.  Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure , 2007, AIDS.

[39]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[40]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[41]  B. LaFleur,et al.  Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART. , 2006, AIDS research and human retroviruses.

[42]  I. James,et al.  Restoration of CD4 T‐cell responses to cytomegalovirus is short‐lived in severely immunodeficient HIV‐infected patients responding to highly active antiretroviral therapy , 2004, HIV medicine.

[43]  Antonio Lanzavecchia,et al.  Central memory and effector memory T cell subsets: function, generation, and maintenance. , 2004, Annual review of immunology.

[44]  B. Walker,et al.  Reconstitution of Virus-Specific CD4 Proliferative Responses in Pediatric HIV-1 Infection 1 , 2003, The Journal of Immunology.

[45]  Jeffrey N. Martin,et al.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.

[46]  D. Scott‐Algara,et al.  Partial Restoration of Cytokine Profile Despite Reconstitution of Cytomegalovirus‐Specific Cell‐Mediated Immunity in Human Immunodeficiency Virus‐Infected Patients During Highly Active Antiretroviral Treatment , 2003, Scandinavian journal of immunology.

[47]  N. Klein,et al.  Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. , 2002, The Journal of infectious diseases.

[48]  D. Nixon,et al.  Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects. , 2001, Virology.

[49]  N. Klein,et al.  Immune repopulation after HAART in previously untreated HIV-1-infected children , 2000, The Lancet.